Manhattan Beach, CA – According to filings with the U.S. Securities and Exchange Commission, Ocular Science is raising $16,916,005.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Anthony Sampietro played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Ocular Science

We believe in ingenuity and innovation to create new solutions to old problems. We are Ocular Science, a leading-edge biotech company focused on developing innovative eye care products at reasonable prices for those suffering from eye disease and discomfort. We do this because eye care patients and physicians should not have to endure Big Pharma’s expensive and overly complex treatments when there are easier and more cost-effective alternatives.

To learn more about Ocular Science, visit http://www.ocularscience.com/

Contact:
Anthony Sampietro, President and Chief Executive Officer
310-662-3763
https://www.linkedin.com/in/anthony-sampietro-476a333/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved